Ashley H.

Ashley H. has over 25 years of work experience in the pharmaceutical and biotechnology industries. Ashley began their career as a Lab Technician at The Scripps Research Institute in 1995. Ashley then moved on to become a Research Associate at The Immune Response Corporation in 1996. In 1999, Ashley became a Policy Intern at the National Human Genome Research Institute. In 2001, they were a Senior Associate of Regulatory and Governmental Affairs at La Jolla Pharmaceutical. In 2005, they were a Senior Regulatory Scientist at Abraxis BioScience. In 2007, they became the Director of World Wide Regulatory Affairs at MedImmune. In 2010, they held two positions, Global Regulatory Lead, Cardiovascular (evolocumab) at Amgen and Vice President of Regulatory Affairs at Micromet. From 2015 to 2021, Ashley held three roles at Esperion - The Lipid Management Company, Chief Regulatory Officer, Chief Development Officer, and Senior Vice President of Global Regulatory Affairs. Most recently, Ashley is the Chief Development Officer (CDO) at Reneo Pharmaceuticals.

Ashley H. attended the University of San Diego School of Law from 1997 to 2000, where they obtained their JD in Law. From 1992 to 1996, they attended UC San Diego, where they earned their BS in Biochemistry, Cell Biology, Philosophy and Ethics. Ashley H. also attended Stanford University Graduate School of Business, though they did not obtain a degree there.